Cargando…

Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity

Group 2 innate lymphoid cells (ILC2) have emerged as a major component of type 2 inflammation in mice and humans. ILC2 secrete large amounts of interleukins 5 and 13, which are largely responsible for host protective immunity against helminth parasites because these cytokines induce profound changes...

Descripción completa

Detalles Bibliográficos
Autores principales: Herbert, De’Broski R., Douglas, Bonnie, Zullo, Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539149/
https://www.ncbi.nlm.nih.gov/pubmed/31072011
http://dx.doi.org/10.3390/ijms20092276
_version_ 1783422317631635456
author Herbert, De’Broski R.
Douglas, Bonnie
Zullo, Kelly
author_facet Herbert, De’Broski R.
Douglas, Bonnie
Zullo, Kelly
author_sort Herbert, De’Broski R.
collection PubMed
description Group 2 innate lymphoid cells (ILC2) have emerged as a major component of type 2 inflammation in mice and humans. ILC2 secrete large amounts of interleukins 5 and 13, which are largely responsible for host protective immunity against helminth parasites because these cytokines induce profound changes in host physiology that include: goblet cell metaplasia, mucus accumulation, smooth muscle hypercontractility, eosinophil and mast cell recruitment, and alternative macrophage activation (M2). This review covers the initial recognition of ILC2 as a distinct cell lineage, the key studies that established their biological importance, particularly in helminth infection, and the new directions that are likely to be the focus of emerging work that further explores this unique cell population in the context of health and disease.
format Online
Article
Text
id pubmed-6539149
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65391492019-06-04 Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity Herbert, De’Broski R. Douglas, Bonnie Zullo, Kelly Int J Mol Sci Review Group 2 innate lymphoid cells (ILC2) have emerged as a major component of type 2 inflammation in mice and humans. ILC2 secrete large amounts of interleukins 5 and 13, which are largely responsible for host protective immunity against helminth parasites because these cytokines induce profound changes in host physiology that include: goblet cell metaplasia, mucus accumulation, smooth muscle hypercontractility, eosinophil and mast cell recruitment, and alternative macrophage activation (M2). This review covers the initial recognition of ILC2 as a distinct cell lineage, the key studies that established their biological importance, particularly in helminth infection, and the new directions that are likely to be the focus of emerging work that further explores this unique cell population in the context of health and disease. MDPI 2019-05-08 /pmc/articles/PMC6539149/ /pubmed/31072011 http://dx.doi.org/10.3390/ijms20092276 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Herbert, De’Broski R.
Douglas, Bonnie
Zullo, Kelly
Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
title Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
title_full Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
title_fullStr Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
title_full_unstemmed Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
title_short Group 2 Innate Lymphoid Cells (ILC2): Type 2 Immunity and Helminth Immunity
title_sort group 2 innate lymphoid cells (ilc2): type 2 immunity and helminth immunity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539149/
https://www.ncbi.nlm.nih.gov/pubmed/31072011
http://dx.doi.org/10.3390/ijms20092276
work_keys_str_mv AT herbertdebroskir group2innatelymphoidcellsilc2type2immunityandhelminthimmunity
AT douglasbonnie group2innatelymphoidcellsilc2type2immunityandhelminthimmunity
AT zullokelly group2innatelymphoidcellsilc2type2immunityandhelminthimmunity